These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38367227)

  • 1. Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery.
    Solidoro R; Centonze A; Miciaccia M; Baldelli OM; Armenise D; Ferorelli S; Perrone MG; Scilimati A
    Med Res Rev; 2024 Jul; 44(4):1800-1866. PubMed ID: 38367227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on fluorescent probes and open-field imaging methods for fluorescence-guided cytoreductive surgery for epithelial ovarian cancer: A review.
    Sun C; Huang Y; Jiang C; Li Z
    BJOG; 2022 Nov; 129 Suppl 2(Suppl 2):50-59. PubMed ID: 36485071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer.
    Hoogstins CE; Tummers QR; Gaarenstroom KN; de Kroon CD; Trimbos JB; Bosse T; Smit VT; Vuyk J; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
    Clin Cancer Res; 2016 Jun; 22(12):2929-38. PubMed ID: 27306792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
    Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
    Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel ovarian cancer-specific fluorescent antibody probe for targeted near-infrared fluorescence imaging.
    Chen J; Zhang C; Guo Y; Chang X; Ma R; Ye X; Cheng H; Li Y; Cui H
    World J Surg Oncol; 2020 Apr; 18(1):66. PubMed ID: 32252772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Covalently Pre-Assembled High-Performance Near-Infrared Fluorescent Molecular Probes for Cancer Imaging.
    Shaw SK; Liu W; Gómez Durán CFA; Schreiber CL; Betancourt Mendiola ML; Zhai C; Roland FM; Padanilam SJ; Smith BD
    Chemistry; 2018 Sep; 24(52):13821-13829. PubMed ID: 30022552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study.
    Harlaar NJ; Koller M; de Jongh SJ; van Leeuwen BL; Hemmer PH; Kruijff S; van Ginkel RJ; Been LB; de Jong JS; Kats-Ugurlu G; Linssen MD; Jorritsma-Smit A; van Oosten M; Nagengast WB; Ntziachristos V; van Dam GM
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):283-290. PubMed ID: 28404198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer.
    Tummers QR; Hoogstins CE; Peters AA; de Kroon CD; Trimbos JB; van de Velde CJ; Frangioni JV; Vahrmeijer AL; Gaarenstroom KN
    PLoS One; 2015; 10(6):e0129766. PubMed ID: 26110901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model.
    Kleinmanns K; Fosse V; Davidson B; de Jalón EG; Tenstad O; Bjørge L; McCormack E
    EBioMedicine; 2020 Jun; 56():102783. PubMed ID: 32454402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models.
    Pu T; Liu Y; Pei Y; Peng J; Wang Z; Du M; Liu Q; Zhong F; Zhang M; Li F; Xu C; Zhang X
    ACS Appl Mater Interfaces; 2023 Jul; 15(27):32226-32239. PubMed ID: 37385963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian Cancer.
    Fung K; Sharma SK; Keinänen O; Roche KL; Lewis JS; Zeglis BM
    Mol Pharm; 2020 Aug; 17(8):3140-3147. PubMed ID: 32644804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer.
    Olson MT; Aguilar EN; Brooks CL; Isder CC; Muilenburg KM; Talmon GA; Ly QP; Carlson MA; Hollingsworth MA; Mohs AM
    Mol Pharm; 2022 Oct; 19(10):3586-3599. PubMed ID: 35640060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Centyrin-Based Near-Infrared Probe for Fluorescence-Guided Surgery of Epidermal Growth Factor Receptor Positive Tumors.
    Mahalingam SM; Dudkin VY; Goldberg S; Klein D; Yi F; Singhal S; O'Neil KT; Low PS
    Bioconjug Chem; 2017 Nov; 28(11):2865-2873. PubMed ID: 28945346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
    Tummers QR; Hoogstins CE; Gaarenstroom KN; de Kroon CD; van Poelgeest MI; Vuyk J; Bosse T; Smit VT; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
    Oncotarget; 2016 May; 7(22):32144-55. PubMed ID: 27014973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe.
    Wang B; Tang C; Lin E; Jia X; Xie G; Li P; Li D; Yang Q; Guo X; Cao C; Shi X; Zou B; Cai C; Tian J; Hu Z; Li J
    EBioMedicine; 2023 Dec; 98():104880. PubMed ID: 38035463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances and perspectives in near-infrared fluorescent organic probes for surgical oncology.
    Xu D; Li L; Chu C; Zhang X; Liu G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1635. PubMed ID: 32297455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model.
    Ceppi L; Bardhan NM; Na Y; Siegel A; Rajan N; Fruscio R; Del Carmen MG; Belcher AM; Birrer MJ
    ACS Nano; 2019 May; 13(5):5356-5365. PubMed ID: 31009198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast and Durable Intraoperative Near-infrared Imaging of Ovarian Cancer Using Ultrabright Squaraine Fluorophores.
    Fukuda T; Yokomizo S; Casa S; Monaco H; Manganiello S; Wang H; Lv X; Ulumben AD; Yang C; Kang MW; Inoue K; Fukushi M; Sumi T; Wang C; Kang H; Bao K; Henary M; Kashiwagi S; Soo Choi H
    Angew Chem Int Ed Engl; 2022 Apr; 61(17):e202117330. PubMed ID: 35150468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The feasibility of folate receptor alpha- and HER2-targeted intraoperative fluorescence-guided cytoreductive surgery in women with epithelial ovarian cancer: A systematic review.
    de Jong JM; Hoogendam JP; Braat AJAT; Zweemer RP; Gerestein CG
    Gynecol Oncol; 2021 Aug; 162(2):517-525. PubMed ID: 34053747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model.
    Debie P; Vanhoeij M; Poortmans N; Puttemans J; Gillis K; Devoogdt N; Lahoutte T; Hernot S
    Mol Imaging Biol; 2018 Jun; 20(3):361-367. PubMed ID: 29090412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.